Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...
Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...
A NEW mum who wanted a new bust after having her baby has lost all of her hair following the operation – including her eyelashes and eyebrows. The silicone implants Czech dental worker ...
Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...
WALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development of its ...
Dallas Cowboys Cheerleader Armani Latimer brought awareness to alopecia on "My Cause, My Cleats" night. ARLINGTON, Texas — It's an annual celebration for the NFL: “My Cause, My Cleats.” The night is ...
Nektar Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric patients 12 years ...
23h
India Today on MSNStress and skin: How mental health affects the largest organ of the bodyStress has a huge impact on the way our skin ages. Stress hormones speed up the ageing process, causing more fine lines and wrinkles.
SAN FRANCISCO - Nektar Therapeutics (NASDAQ:NKTR) announced today that its drug candidate, rezpegaldesleukin, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results